User profiles for George Jour
George JourNYU Verified email at nyumc.org Cited by 2341 |
Angiogenesis in melanoma: an update with a focus on current targeted therapies
Angiogenesis plays a crucial role in melanoma metastasis and progression. In recent years,
numerous studies have investigated the prognostic and clinical significance of this …
numerous studies have investigated the prognostic and clinical significance of this …
Role of angiogenesis in melanoma progression: Update on key angiogenic mechanisms and other associated components
Angiogenesis, the formation of new blood vessels from existing blood vessels, is a complex
and highly regulated process that plays a role in a wide variety of physiological and …
and highly regulated process that plays a role in a wide variety of physiological and …
[HTML][HTML] Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms
The dynamics of viral load (VL) of the severe acute respiratory syndrome coronavirus 2 and
its association with different clinical parameters remain poorly characterized in the US …
its association with different clinical parameters remain poorly characterized in the US …
[HTML][HTML] Renal neuroendocrine tumors
Objectives: Neuroendocrine tumors (NETs) are uncommon tumors that exhibit a wide range
of neuroendocrine differentiation and biological behavior. Primary NETs of the kidney, …
of neuroendocrine differentiation and biological behavior. Primary NETs of the kidney, …
[HTML][HTML] Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome
…, S Banakis, L Perez-Perez, G Shen, G Jour… - Nature …, 2021 - nature.com
Respiratory failure is associated with increased mortality in COVID-19 patients. There are
no validated lower airway biomarkers to predict clinical outcome. We investigated whether …
no validated lower airway biomarkers to predict clinical outcome. We investigated whether …
Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma
The Risk Model is a validated outcome predictor for patients with head and neck squamous
cell carcinoma (Brandwein-Gensler et al. in Am J Surg Pathol 20:167–178, 2005 ; Am J Surg …
cell carcinoma (Brandwein-Gensler et al. in Am J Surg Pathol 20:167–178, 2005 ; Am J Surg …
Using machine learning algorithms to predict immunotherapy response in patients with advanced melanoma
Purpose: Several biomarkers of response to immune checkpoint inhibitors (ICI) show
potential but are not yet scalable to the clinic. We developed a pipeline that integrates deep …
potential but are not yet scalable to the clinic. We developed a pipeline that integrates deep …
Autoimmune dermatologic toxicities from immune checkpoint blockade with anti‐PD‐1 antibody therapy: a report on bullous skin eruptions
G Jour, IC Glitza, RM Ellis… - Journal of cutaneous …, 2016 - Wiley Online Library
Monoclonal antibodies against the immune checkpoint programmed cell death receptor 1 (
PD ‐1) improve the hosts' antitumor immune response and have showed tremendous …
PD ‐1) improve the hosts' antitumor immune response and have showed tremendous …
Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region
…, V Raabe, MI Samanovic, G Jour… - Genome …, 2020 - genome.cshlp.org
Effective public response to a pandemic relies upon accurate measurement of the extent and
dynamics of an outbreak. Viral genome sequencing has emerged as a powerful approach …
dynamics of an outbreak. Viral genome sequencing has emerged as a powerful approach …
Clinical genomic sequencing of pediatric and adult osteosarcoma reveals distinct molecular subsets with potentially targetable alterations
Purpose: Although multimodal chemotherapy has improved outcomes for patients with
osteosarcoma, the prognosis for patients who present with metastatic and/or recurrent disease …
osteosarcoma, the prognosis for patients who present with metastatic and/or recurrent disease …